ACBD5 | Acyl-CoA binding domain containing 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AKAP1 | A kinase (PRKA) anchor protein 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ARL6IP5 | ADP-ribosylation factor-like 6 interacting protein 5 | Predicted membrane proteins
| | | | | Expressed in all |
ARMC10 | Armadillo repeat containing 10 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARSD | Arylsulfatase D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATM | ATM serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C14orf2 | Chromosome 14 open reading frame 2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV3 | Caveolin 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CCDC51 | Coiled-coil domain containing 51 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CCDC90B | Coiled-coil domain containing 90B | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH15 | Cadherin 15, type 1, M-cadherin (myotubule) | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
COX4I1 | Cytochrome c oxidase subunit IV isoform 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
COX6C | Cytochrome c oxidase subunit VIc | Cancer-related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CS | Citrate synthase | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CX3CL1 | Chemokine (C-X3-C motif) ligand 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CXADR | Coxsackie virus and adenovirus receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
DDO | D-aspartate oxidase | Enzymes Predicted membrane proteins
| | | | | Mixed |